Education
About Us
Working with TipRanks
Follow Us
GlaxoSmithKline (GSK)
NYSE:GSK
GSK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$31.72 - $44.67
Previous CloseN/A
Volume981.79K
Average Volume (3M)4.76M
Market Cap
$77.59B
Enterprise Value$134.22B
Total Cash (Recent Filing)$4.49B
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)19.6
Beta0.31
Next Earnings
Jul 30, 2025EPS Estimate
1.16Last Dividend Ex-Date
May 16, 2025Dividend Yield4.5%
Share Statistics
EPS (TTM)1.20
Shares Outstanding2,043,871,000
10 Day Avg. Volume5,068,451
30 Day Avg. Volume4,758,092
Financial Highlights & Ratios
PEG Ratio-2.17
Price to Book (P/B)11.04
Price to Sales (P/S)0.00
P/FCF Ratio22.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$40.42Price Target Upside5.87% Upside
Rating ConsensusHold
Number of Analyst Covering3
GlaxoSmithKline News
Bulls Say, Bears Say
Bulls Say
AcquisitionThe acquisition of efimosfermin expands GSK's hepatology portfolio and fits within the company's business development strategy.
Market PositionThe RSV market is expected to be dominated by GSK and Pfizer, potentially boosting GSK's market presence.
Product DevelopmentGSK stands to benefit from R&D synergies due to ongoing development efforts, enhancing its liver-related portfolio.
Bears Say
Manufacturing ComplexityThe manufacturing process for Trelegy is more complicated than other devices, which could pose challenges.
Vaccine Market SentimentPublic sentiment on vaccines may not shift positively unless serious infectious disease outbreaks occur.
Ownership Overview
―
Insiders
6.31% Mutual Funds
10.39% Other Institutional Investors
83.03% Public Companies and Individual Investors
GSK FAQ
What was GlaxoSmithKline’s price range in the past 12 months?
GlaxoSmithKline lowest stock price was $31.71 and its highest was $44.67 in the past 12 months.
What is GlaxoSmithKline’s market cap?
GlaxoSmithKline’s market cap is $77.59B.
When is GlaxoSmithKline’s upcoming earnings report date?
GlaxoSmithKline’s upcoming earnings report date is Jul 30, 2025 which is in 22 days.
How were GlaxoSmithKline’s earnings last quarter?
GlaxoSmithKline released its earnings results on Apr 30, 2025. The company reported $1.199 earnings per share for the quarter, beating the consensus estimate of $1.045 by $0.154.
Is GlaxoSmithKline overvalued?
According to Wall Street analysts GlaxoSmithKline’s price is currently Undervalued.
Does GlaxoSmithKline pay dividends?
GlaxoSmithKline pays a Quarterly dividend of $0.429 which represents an annual dividend yield of 4.5%. See more information on GlaxoSmithKline dividends here
What is GlaxoSmithKline’s EPS estimate?
GlaxoSmithKline’s EPS estimate is 1.16.
How many shares outstanding does GlaxoSmithKline have?
GlaxoSmithKline has 2,043,871,000 shares outstanding.
What happened to GlaxoSmithKline’s price movement after its last earnings report?
GlaxoSmithKline reported an EPS of $1.199 in its last earnings report, beating expectations of $1.045. Following the earnings report the stock price went up 2.258%.
Which hedge fund is a major shareholder of GlaxoSmithKline?
Currently, no hedge funds are holding shares in GSK
GlaxoSmithKline Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$40.42 (5.87% Upside)
$40.42 (5.87% Upside)
Blogger Sentiment
Bullish
GSK Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 19.9M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days >0.1%
Last 30 Days ▼ 2.2%
Last 30 Days ▼ 2.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.54%
12-Months-Change
Fundamentals
Return on Equity
22.26%
Trailing 12-Months
Asset Growth
6.01%
Trailing 12-Months
Company Description
GlaxoSmithKline
GlaxoSmithKline (GSK) is a global healthcare company headquartered in the United Kingdom, specializing in the research, development, and manufacturing of pharmaceutical medicines, vaccines, and consumer healthcare products. GSK operates in three main sectors: Pharmaceuticals, Vaccines, and Consumer Healthcare, with a focus on innovative solutions for disease prevention and treatment. The company is committed to improving global health and well-being through its diverse product portfolio, which addresses a wide range of medical conditions and consumer needs.
GSK Company Deck
GSK Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong growth in specialty medicines and promising R&D advancements, positioning GSK for continued success. However, challenges such as declining vaccine sales, macroeconomic uncertainties, and impacts from Medicare Part D redesign were notable concerns. Despite these issues, the overall sentiment remains positive due to strategic growth areas and confident long-term outlooks.Read More>GSK Stock 12 Month Forecast
Average Price Target
$40.42
▲(5.87%Upside)